Delivery Order SPE2DB24D8003-SPE2DB25FJTPG
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The $5,441.71 firm fixed-price contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.0.5ML pharmaceutical products. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024.
Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,101.32 firm fixed price contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that enables the company to provide...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the purchase of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a total ceiling value of $15,933.58 and a period of performance through November 18, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT...
This is a Delivery Order federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract, valued at $1,589.95, has a firm fixed-price pricing type and a completion date of November 6, 2024. The award is not designated as a set-aside contract.
This Delivery Order is issued under Dakota Drug, Inc.'s existing Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of pharmaceutical products and medical supplies. The contract has a ceiling value of $1,381.65 and a period of performance extending through November 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which is part of the DLA Troop Support Medical's ECAT Generation V...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $9,080.31 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4559106710 MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract is part of the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. Dakota Drug, Inc. holds a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with a performance period extending through December 31, 2025.
The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award ID is SPE2DB24D8003 and SPE2DB24FJTQC, with a ceiling value of $1,588.86. It is a firm fixed-price delivery order contract with an ultimate completion date of October 10, 2024.
The contract is not set aside and is part of the DLA Troop Support...
This federal contract award, identified as SPE2DX15D8001|SPE2DX23FBQCN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $7,745.85 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including insulin pens, inhalers, anticoagulants, and biologic drugs, to support U.S. Armed Forces medical...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation.
The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders....